| Philipp von Hugo |
Philipp von Hugo is currently the VP and Head of Global Legal Affairs & Compliance at QIAGEN NV since 2003. He previously worked as the Head of Legal Affairs & Human Resources at Cardion GmbH. In 2022-2023, he served as an Independent Director at Immunovia AB. Dr. Hugo holds a doctorate degree from the University of Kiel. |
| Lezette Young |
Lezette Young currently works as a Manager-Global Compliance at QIAGEN NV. |
| Stephany Foster |
Stephany Foster is currently the Senior Vice President & Head-Human Resources at QIAGEN NV. Previously, she served as an Independent Director at OncoSec Medical, Inc. from 2022 to 2023. She also worked as an Internal Auditor at MorganFranklin Consulting LLC and Independence Air, Inc. Ms. Foster holds undergraduate and graduate degrees from the University of Notre Dame. |
| Thierry Bernard |
Thierry Bernard is currently the Chief Executive Officer & Managing Director at QIAGEN NV since 2019. He is also the Chief Executive Officer & Director at Natixis Immo Développement SA, Chief Executive Officer at QIAGEN Gdansk Sp zoo, Chief Executive Officer at QIAGEN Srl, Chairman at QIAGEN Marseille SA since 2021, Chairman at AdvaMedDx since 2023, Chairman at Société des Peintures Europeennes SAS, Director at Huttopia SA, Director at QIAGEN Manchester Ltd. since 2017, Director at First Light Diagnostics, Inc., Director at International Factors Italia SpA, Director at Business Partner Italia ScpA, and Director at QIAGEN, Inc. (Canada). Previously, he served as the Chief Financial Officer at Banca Nazionale del Lavoro SpA starting in 2018. He was also a Member of Conseillers du Commerce Extérieur de la France and French Foreign Trade Advisors. Prior to his current and former positions, Mr. Bernard held the role of Chairman at Panoranet SAS and Fincorp SAS, Director at Daktari Diagnostics, Inc., Communications Director at TDF SAS, and Vice President-Global Commercial Operations at bioMérieux SA from 2012 to 2014. Mr. Bernard's education includes a graduate degree from the London School of Economics & Political Science in 1988, an undergraduate degree from Sciences Po, a graduate degree from the College of Europe, and an undergraduate degree from Harvard Business School in 2009. |
| Lawrence A. Rosen |
Lawrence A. Rosen is currently the Chairman-Supervisory Board at QIAGEN NV, QIAGEN GmbH, and QIAGEN Srl. He is also a Member-Supervisory Board at Lanxess AG and an Independent Member-Supervisory Board at Deutsche Post AG. In his former positions, he served as the Chief Financial Officer at Fresenius Medical Care AG, the Head-Finance & Treasury at Hoechst AG, and the Treasurer & Senior Vice President at Aventis SA. He also held various roles at Deutsche Post AG, including CFO, Head-Finance & Global Business Services, and served as a Member-Supervisory Board at Deutsche Postbank AG. Additionally, he was the Chief Financial Officer at Deutsche Post DHL Research & Innovation GmbH. Mr. Rosen holds an MBA from the University of Michigan and an undergraduate degree from The State University of New York. |
| Roland Sackers |
Roland Sackers currently works at QIAGEN Marseille SA, as Chief Executive Officer & Director, Evotec SE, as Vice Chairman-Supervisory Board from 2021, Cellestis GmbH, as Chairman, and various other companies. Mr. Sackers also formerly worked at Exiqon A, as Vice Chairman, QIAGEN Sciences, Inc., as Chairman, Corbett Life Science Pty Ltd., as Chairman, and various other companies. Mr. Sackers received his Masters Business Admin degree in 1995 from the University of Münster. |
| Metin Colpan |
Metin Colpan is the founder of QIAGEN NV, QIAGEN Srl, and QIAGEN GmbH, which were founded in 1996, 1984, and 1984 respectively. He holds the title of Independent Member-Supervisory Board at QIAGEN NV starting in 2004. He is also the founder of GenPat77 Pharmacogenetics AG. Dr. Colpan's current jobs include being the Managing Director at CC Verwaltungs GmbH, the Director at EM Brake Systems AG, the Managing Director at MC VV GmbH & Co. KG, and a Member-Supervisory Board at CGR B-E GmbH and Heilpflanzenwohl AG. His former jobs include being a Member-Supervisory Board at GPC Biotech AG, MorphoSys AG, Ingenium Pharmaceuticals GmbH, and Qalovis GmbH. Dr. Colpan obtained his graduate degree in 1980 and his doctorate degree in 1983 from Technische Universität Darmstadt. Dr. Colpan is also the founder of GenPat77 Pharmacogenetics AG. |
| Antonio Santos |
Antonio Santos is currently the Senior Vice President & Head-Global Operations at QIAGEN NV. Previously, he held the position of SVP-Americas Operations at bioMérieux, Inc. and Vice President-Operations at RBC Post Corp. Mr. Santos holds an MBA from Rutgers State University of New Jersey and an undergraduate degree from Universidade Nova de Lisboa. |
